NASDAQ:NEPTNeptune Wellness Solutions Stock Price, Forecast & News

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NEPT stock has increased by 152.1% and is now trading at $3.05. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neptune Wellness Solutions.

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Wednesday, June 10th 2020. View our earnings forecast for Neptune Wellness Solutions.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) issued its earnings results on Wednesday, October, 12th. The biotechnology company reported ($0.02) EPS for the quarter. The biotechnology company had revenue of $8.91 million for the quarter. Neptune Wellness Solutions had a negative net margin of 132.09% and a negative return on equity of 39.22%. View Neptune Wellness Solutions' earnings history.

Neptune Wellness Solutions updated its first quarter 2021 IntraDay earnings guidance on Thursday, May, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $18-22 million.

3 equities research analysts have issued 1-year target prices for Neptune Wellness Solutions' shares. Their forecasts range from $3.75 to $3.75. On average, they expect Neptune Wellness Solutions' stock price to reach $3.75 in the next year. This suggests a possible upside of 23.0% from the stock's current price. View analysts' price targets for Neptune Wellness Solutions.

Media stories about NEPT stock have been trending somewhat positive recently, according to InfoTrie. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Neptune Wellness Solutions earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the stock's share price in the near term. View the latest news aboutNeptune Wellness Solutions.

Neptune Wellness Solutions saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,430,000 shares, an increase of 14.1% from the April 30th total of 7,390,000 shares. Based on an average daily trading volume, of 1,310,000 shares, the days-to-cover ratio is currently 6.4 days. Approximately 11.0% of the company's stock are short sold. View Neptune Wellness Solutions' Current Options Chain.

Some companies that are related to Neptune Wellness Solutions include Arcturus Therapeutics (ARCT), Myovant Sciences (MYOV), I-Mab (ARQT), Enanta Pharmaceuticals (ENTA), Aimmune Therapeutics (AIMT), Rocket Pharmaceuticals (RCKT), Applied Therapeutics (APLT), Phibro Animal Health (PAHC), Odonate Therapeutics (ODT), BioXcel Therapeutics (BTAI), Stoke Therapeutics (STOK), NextCure (NXTC), Athenex (ATNX), ImmunoGen (IMGN) and Rhythm Pharmaceuticals (RYTM). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Amarin (AMRN), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), Crispr Therapeutics (CRSP) and Sangamo Therapeutics (SGMO).

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Neptune Wellness Solutions' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include AdvisorShares Investments LLC (0.42%), Deutsche Bank AG (0.24%), White Pine Capital LLC (0.12%) and Two Sigma Investments LP (0.06%).

NEPT stock was purchased by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Two Sigma Investments LP, White Pine Capital LLC, and AdvisorShares Investments LLC.

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NEPT stock can currently be purchased for approximately $3.05.

Neptune Wellness Solutions has a market capitalization of $289.94 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]